Only a handful of studies have explored molecular and epigenetic regulation of cldn5 despite its role in several inflammatory conditions and neurological disorders, including stroke (25), glioblastoma (26), multiple sclerosis, and Alzheimer’s disease (27). This evidence concerns the gene CLDN5 and nervous system disorder.